JOLT
发表于 2025-3-21 18:33:52
书目名称Cancer Immunology影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0221125<br><br> <br><br>书目名称Cancer Immunology影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0221125<br><br> <br><br>书目名称Cancer Immunology网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0221125<br><br> <br><br>书目名称Cancer Immunology网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0221125<br><br> <br><br>书目名称Cancer Immunology被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0221125<br><br> <br><br>书目名称Cancer Immunology被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0221125<br><br> <br><br>书目名称Cancer Immunology年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0221125<br><br> <br><br>书目名称Cancer Immunology年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0221125<br><br> <br><br>书目名称Cancer Immunology读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0221125<br><br> <br><br>书目名称Cancer Immunology读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0221125<br><br> <br><br>
nullify
发表于 2025-3-21 23:43:11
http://reply.papertrans.cn/23/2212/221125/221125_2.png
sphincter
发表于 2025-3-22 02:23:55
http://reply.papertrans.cn/23/2212/221125/221125_3.png
不利
发表于 2025-3-22 07:49:33
Immunopathology and Immunotherapy of Myeloid Leukemia,oliferation, and resistance to apoptosis. It is now generally accepted that AML originates from genetic alterations in normal hematopoietic stem cells (HSC) or common myeloid progenitor cells, giving rise to the leukemic stem cell (LSC), from which the bulk of leukemic blasts arise, ultimately leadi
摇摆
发表于 2025-3-22 12:29:08
Immunopathology and Immunotherapy of Acute Lymphoblastic Leukemia, based therapies. The immunophenotype is the basis for the current ALL subclassification. Specific monoclonal antibodies against cell surface marker such as CD20, CD22, or CD52 are now part of standard care of ALL treatment..Furthermore, also the introduction of bispecific monoclonal antibodies comb
简略
发表于 2025-3-22 15:37:55
http://reply.papertrans.cn/23/2212/221125/221125_6.png
简略
发表于 2025-3-22 18:12:13
http://reply.papertrans.cn/23/2212/221125/221125_7.png
啤酒
发表于 2025-3-23 00:03:08
Immunotherapy of Gastric and Esophageal Cancers,nd therapeutic modalities, patients are still diagnosed at late stages and have low rates of survival. Recently, immunotherapeutic modalities have shown promising results in improving survival of patients when used as a single agent or in combination with conventional chemotherapy. Gastric and esoph
Antimicrobial
发表于 2025-3-23 01:49:23
Hepatobiliary Tumors: Immunopathology and Immunotherapy,ciated with chronic viral hepatitis and cirrhosis. Conventional treatments such as chemotherapy and radiotherapy are not efficient enough to eliminate residual cancer cells. In recent years, tumor immunotherapy has emerged as a perfect method, in terms of delaying the progression of advanced tumors
延期
发表于 2025-3-23 07:33:14
http://reply.papertrans.cn/23/2212/221125/221125_10.png